Taich Adam, CFO of 10x Genomics ($TXG), sold shares on the open market four times in the last year, totaling about $734 thousand. His most recent sale occurred on February 23, 2026. These sales rank 5,631st among 11,678 insiders in our database, where the average is $8.6 million across about six transactions. Adam made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | A | Class A Common Stock | 106579 | $0.00 | 394,996.0000 | 127,691,329 | 36.95% | 0.08% |
| Feb. 23, 2026 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | S | Class A Common Stock | 8968 | $18.58 | 288,417.0000 | 127,691,329 | 3.02% | 0.01% |
| Nov. 24, 2025 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | S | Class A Common Stock | 11888 | $19.00 | 297,385.0000 | 125,502,291 | 3.84% | 0.01% |
| Aug. 22, 2025 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | S | Class A Common Stock | 22315 | $13.79 | 309,273.0000 | 120,451,550 | 6.73% | 0.02% |
| May 22, 2025 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | S | Class A Common Stock | 4044 | $8.30 | 331,588.0000 | 120,451,550 | 1.20% | 0.00% |
| March 17, 2025 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | A | Class A Common Stock | 133928 | $0.00 | 335,632.0000 | 120,451,550 | 66.40% | 0.11% |
| Oct. 23, 2024 | 10x Genomics, Inc. | $TXG | Taich Adam | Chief Financial Officer | A | Class A Common Stock | 201704 | $0.00 | 201,704.0000 | 120,733,030 | 9999.99% | 0.17% |